Collectively, the present study is the first to investigate cyclin F and SPDL1 proteins in pancreatic adenocarcinoma, and one of the few that assessed RRM2 in this group of cancer patients. This evidence concerns the gene SPDL1 and pancreatic adenocarcinoma.